Discrepancy between patient‐ and healthcare provider‐reported adverse drug reactions in inflammatory bowel disease patients on biological therapy

BACKGROUND: Only limited data is available on the extent and burden of adverse drug reactions (ADRs) to biological therapy in inflammatory bowel disease (IBD) patients in daily practice, especially from a patient's perspective. OBJECTIVE: The aim of this study was to systematically assess patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Pepijn W. A., Römkens, Tessa E. H., West, Rachel L., Russel, Maurice G. V. M., Jansen, Jeroen M., van Lint, Jette A., Jessurun, Naomi T., Hoentjen, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Inflammatory Bowel Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498403/
https://www.ncbi.nlm.nih.gov/pubmed/34077634
http://dx.doi.org/10.1002/ueg2.12107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498403/
https://www.ncbi.nlm.nih.gov/pubmed/34077634
http://dx.doi.org/10.1002/ueg2.12107

Ejemplares similares